SU

Suven Pharmaceuticals LtdNSE SUVENPHAR Stock Report

Last reporting period 31 Mar, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

1.471

Small

Exchange

XNSE - National Stock Exchange Of India

View Section: Financials

Suven Statements

SU

Suven Income Statement

B

M

INR (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2024-03-31
%

4 727.5

100

2 280.82

47.5

2 446.68

52.5

0

785.99

15.6

1 305.85

30.3

1 140.83

22.2

-58.018

-0.9

313.98

6.7

1 363.2

28

361.94

6.9

1 001.27

21.1

3.936

254.36

2023-09-30
%

5 786.04

100

2 204.29

37.6

3 581.75

62.4

65.619

1.9

573.21

12.4

1 176.81

25.1

2 404.94

37.3

-16.493

-0.2

305.07

8.6

2 693.51

45.6

691.97

11.2

2 001.54

34.4

7.87

254.3

2023-03-31
%

7 231.26

100

3 139

42.5

4 092.26

57.5

42.79

0.5

552.82

6.9

1 176.56

15

2 915.8

42.5

-36.886

-0.6

244.09

3.1

3 122.91

45

806

11.4

2 316.91

33.6

9.096

254.75

2022-09-30
%

6 172

100

2 715.2

47.5

3 456.8

52.5

43

0.7

552.4

10.3

1 184.5

21

2 272.3

31.6

-17.4

-0.1

219.5

3.9

2 474.4

35.4

678.4

9.5

1 796

25.9

7.05

254.7

2022-03-31
%

7 554.4

100

3 203.8

42.5

4 350.6

57.5

43.3

0.6

561.3

8.6

1 129.4

17.2

3 221.1

40.3

-29.3

-0.6

815.6

4.6

4 007.4

44.3

1 490

19.1

2 517.4

25.2

9.89

254.65

2021-09-30
%

5 647.9

100

2 519.1

45.3

3 128.7

54.7

60.2

1.2

443.5

7.7

946.7

17.3

2 182.2

37.4

378.1

5.4

108.2

1.7

2 668.5

44.5

647.8

12.3

2 020.6

32.2

7.94

254.45

2021-03-31
%

5 340.9

100

2 377.7

52.5

2 963.3

47.5

41.7

0.6

378.6

6.4

834.9

15.3

2 128.4

32.2

319.9

7.2

81.4

1.3

2 529.7

40.7

562.2

8.6

1 967.5

32.1

7.72

254.75

View Section: Balance Sheet